The Royal Family is so steeped in tradition and protocol that its members were taught royal etiquette by household staff from ...
William Blair reduced their Q1 2026 EPS estimates for Bristol-Myers Squibb in a research report issued to clients and ...
William Blair reduced their Q1 2025 earnings per share (EPS) estimates for Sapiens International in a report released on Tuesday, February 18th. William Blair analyst D. Becker now anticipates that ...
Hosted on MSN1d
William Blair Downgrades Booz Allen Hamilton Holding (BAH)Fintel reports that on February 21, 2025, William Blair downgraded their outlook for Booz Allen Hamilton Holding (NYSE:BAH) from Outperform to Market Perform. Analyst Price Forecast Suggests 42.38% ...
Fintel on MSN1d
William Blair Downgrades General Dynamics (GD)Fintel reports that on February 21, 2025, William Blair downgraded their outlook for General Dynamics (NYSE:GD) from ...
The U.S. Department of Defense has launched a massive review of consulting services contracts, with an eye toward making cuts ...
William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...
William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...
Regulatory challenges have marred progress in the sector in the past. Learn why Indians are among the largest data consumers ...
In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Cardiff Oncology (CRDF – Research Report). The company’s ...
Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback